{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:19:05Z","timestamp":1725617945689},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,18]]},"DOI":"10.7759\/cureus.18850","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T09:17:47Z","timestamp":1634548667000},"source":"Crossref","is-referenced-by-count":1,"title":["Thromboembolic Risk in COVID-19 Patients: Is There a Hidden Link?"],"prefix":"10.7759","author":[{"given":"Jos\u00e9","family":"Cidade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lder","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Maltez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok FA","year":"2020","unstructured":"Klok FA, Kruip MJ, van der Meer NJ, et al.. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-7. 10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01327-9","article-title":"Venous thromboembolism in COVID-19: towards an ideal approach to thromboprophylaxis, screening, and treatment","volume":"22","author":"Aryal MR","year":"2020","unstructured":"Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P. Venous thromboembolism in COVID-19: towards an ideal approach to thromboprophylaxis, screening, and treatment. Curr Cardiol Rep. 2020, 22:52. 10.1007\/s11886-020-01327-9","journal-title":"Curr Cardiol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-0233-6","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin YH","year":"2020","unstructured":"Jin YH, Cai L, Cheng ZS, et al.. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020, 7:4. 10.1186\/s40779-020-0233-6","journal-title":"Mil Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12880","article-title":"The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study","volume":"13","author":"Shi C","year":"2020","unstructured":"Shi C, Wang C, Wang H, et al.. The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study. Clin Transl Sci. 2020, 13:1087-95. 10.1111\/cts.12880","journal-title":"Clin Transl Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-9. 10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","volume":"46","author":"Alhazzani W","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, et al.. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020, 46:854-87. 10.1007\/s00134-020-06022-5","journal-title":"Intensive Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02235-z","article-title":"Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis","volume":"50","author":"Hasan SS","year":"2020","unstructured":"Hasan SS, Radford S, Kow CS, Zaidi ST. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020, 50:814-21. 10.1007\/s11239-020-02235-z","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3840-z","article-title":"Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis","volume":"41","author":"Beitland S","year":"2015","unstructured":"Beitland S, Sandven I, Kj\u00e6rvik LK, Sandset PM, Sunde K, Eken T. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015, 41:1209-19. 10.1007\/s00134-015-3840-z","journal-title":"Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos AC","year":"2020","unstructured":"Lemos AC, do Esp\u00edrito Santo DA, Salvetti MC, Gilio RN, Agra LB, Pazin-Filho A, Miranda CH. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thromb Res. 2020, 196:359-66. 10.1016\/j.thromres.2020.09.026","journal-title":"Thromb Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004548","article-title":"Higher intensity thromboprophylaxis regimens and pulmonary embolism in critically ill coronavirus disease 2019 patients","volume":"48","author":"Taccone FS","year":"2020","unstructured":"Taccone FS, Gevenois PA, Peluso L, et al.. Higher intensity thromboprophylaxis regimens and pulmonary embolism in critically ill coronavirus disease 2019 patients. Crit Care Med. 2020, 48:e1087-90. 10.1097\/CCM.0000000000004548","journal-title":"Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe I","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A, et al.. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020, 76:122-4. 10.1016\/j.jacc.2020.05.001","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.30.20117929","article-title":"Therapeutic anticoagulation is associated with decreased mortality in mechanically ventilated COVID-19 patients","author":"Trinh MA","year":"2020","unstructured":"Trinh MA, Chang DR, Govindarajulu US, et al.. Therapeutic anticoagulation is associated with decreased mortality in mechanically ventilated COVID-19 patients. medRxiv. 2020, 10.1101\/2020.05.30.20117929","journal-title":"medRxiv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system","volume":"324","author":"Bilaloglu S","year":"2020","unstructured":"Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020, 324:799-801. 10.1001\/jama.2020.13372","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari H","year":"2020","unstructured":"Al-Samkari H, Karp Leaf RS, Dzik WH, et al.. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020, 136:489-500. 10.1182\/blood.2020006520","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243705","article-title":"Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"15","author":"Piscoya A","year":"2020","unstructured":"Piscoya A, Ng-Sueng LF, Parra Del Riego A, et al.. Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. PLoS One. 2020, 15:e0243705. 10.1371\/journal.pone.0243705","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui S","year":"2020","unstructured":"Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020, 18:1421-4. 10.1111\/jth.14830","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13613719","article-title":"Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients","volume":"13","author":"Miron MJ","year":"1999","unstructured":"Miron MJ, Perrier A, Bounameaux H, de Moerloose P, Slosman DO, Didier D, Junod A. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur Respir J. 1999, 13:1365-70. 10.1183\/09031936.99.13613719","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01647-2019","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)","volume":"54","author":"Konstantinides SV","year":"2019","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019, 54:10.1183\/13993003.01647-2019","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74325-thromboembolic-risk-in-covid-19-patients-is-there-a-hidden-link","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:32Z","timestamp":1707507092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74325-thromboembolic-risk-in-covid-19-patients-is-there-a-hidden-link"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.18850","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}